Status:

UNKNOWN

Hypnosis and Direct Autonomic Experience Influence on Chronic Symptoms

Lead Sponsor:

Inner Group Inc.

Conditions:

Restless Legs Syndrome

Multiple Sclerosis

Eligibility:

All Genders

12+ years

Brief Summary

Study will look at a limited number of participants with various chronic symptoms. Investigating a new and novel form of hypnosis application called "Direct Autonomic Experience (DAX)" which is using ...

Detailed Description

Hypnosis and Direct Autonomic Experience Influence on Chronic Symptoms One common characteristic of many chronic conditions is the neurology/ biology/ symptomology may change slightly or signficantly ...

Eligibility Criteria

Inclusion

  • Participant must have a proper medical diagnosis of chronic condition.
  • Existing medical treatments are having little to no effect on a discomfort metric to measure
  • SUDS to be evaluated could be physical or emotional in nature (e.g. Anxiety level, or Leg Cramping/moving)
  • Must be motivated and willing to participate in a study that uses hypnosis, placebo and/or nocebo type mental matters.
  • Participant must continue existing medical treatments (as recommended/adjusted by such outside professionals) and continue to see and be monitored by new/existing medical professionals during the term of study.
  • Must have technology of computers/internet/support to be able to attend regular video chat/conferences for needed interactions with study.
  • Must have schedule availability and flexibility to meet in video chats/conferences as required.
  • Must have the computer skills/resources and aptitude to handle video chat/conference and able to have resources/friends/knowledge that can help if technical issues arise to allow conference to occur (can handle restarting a video conference if crashes or network acts up)

Exclusion

  • Acute and short term discomfort matters not being measured that outside scope of chronic condition.
  • Must not be active in any other studies or such studies deemed to not interact with this.
  • Does not have a properly diagnosed chronic condition (exception are control subjects)

Key Trial Info

Start Date :

March 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 1 2021

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04303143

Start Date

March 1 2021

End Date

July 1 2021

Last Update

July 29 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.